November 25, 2022
1 min watch
NEW YORK — In this video, David Eichenbaum, MD, director of research at Retina Vitreous Associates of Florida, discussed the outlook for oral therapies in the treatment of geographic atrophy at OSN New York Retina.
Eichenbaum said that oral therapies might provide an easier experience for patients over gene therapies and could ideally work in concert with other therapy programs.
“The ultimate path to treatment may actually include a combination of these therapies inhibiting complement in multiple different ways,” Eichenbaum said.